
News|Articles|June 1, 2003
Velcade (Bortezomib for injection) Millennium
Multiple myeloma treatment represents new class: proteasome inhibitors
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
National Alliance survey shows employers are leaving the ‘big 3’ for other PBMs
2
7 takeaways from the MHE webinar on PBM reform and transparency
3
Novo Nordisk's ziltivekimab falls short to reduce cardiovascular events in phase 3 trial
4
What employees may miss when they buy drugs directly online
5





















